Reduction in PGE2 Levels with Photobiomodulation Therapy vs Sham for Non-Specific Low Back Pain
How to Cite
OrthoEvidence. Reduction in PGE2 Levels with Photobiomodulation Therapy vs Sham for Non-Specific Low Back Pain. ACE Report. 2021;14(1):2. Available from: https://myorthoevidene.com/AceReport/Report/13276
Photobiomodulation Therapy is Able to Modulate PGE 2 Levels in Patients With Chronic Non-Specific Low Back Pain: A Randomized Placebo-Controlled TrialLasers Surg Med. 2021 Feb;53(2): 236-244.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Eighteen patients with chronic non-specific low back pain were randomized to receive a single session of photobiomodulation therapy (n=9) or sham therapy (n=9) for the modulation of inflammatory markers and relief of pain. The primary outcome of interest was prostaglandin E2 (PGE2) levels. Secondary outcomes of interest included tumour necrosis factor alpha (TNF-a), interleukin (IL)-6 levels, and ...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE